| Association of Cognition With Functional Mobility in People With Alzheimer's Disease (NCT05113732) | Istanbul University - Cerrahpasa | 2021-11-01 |
| Deep Brain Stimulation for Alzheimer's Disease (NCT03959124) | Buddhist Tzu Chi General Hospital | 2020-04-06 |
| Technology Intervention to Support Caregiving for Alzheimer's Disease (I-CARE) (NCT03119259) | Indiana University | 2019-11-25 |
| Intervention of Intestinal Microorganism in Mild Cognitive Impairment (NCT03991195) | XuanwuH 2 | 2019-08-31 |
| Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)" (NCT03890861) | Pennington Biomedical Research Center | 2019-08-09 |
| Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS (NCT03846492) | Centre for Addiction and Mental Health | 2019-04-24 |
| Movement Intervention for Memory Enhancement (NCT03475316) | Albert Einstein College of Medicine | 2019-03-28 |
| Effects on the Olfactory Epithelium and the Olfactory Nerve From Exposure to Diesel Exhaust (NCT07237958) | Umeå University | 2019-02-01 |
| Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type (NCT03721705) | Renew Research, LLC | 2018-11-12 |
| Studies of Brain and Body Interaction (NCT03672266) | Rutgers University | 2018-08-01 |
| Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study) (NCT03661034) | Cognito Therapeutics, Inc. | 2018-05-31 |
| Multi-Center Study of Sensory Stimulation to Improve Brain Function (NCT03556280) | Cognito Therapeutics, Inc. | 2018-04-24 |
| Partners at Meals - Respite Care and Home (PAM) (NCT03622814) | Medical University of South Carolina | 2017-08-15 |
| Photobiomodulation for Improving Brain Function in Dementia (PBM Dementia) (NCT03160027) | University of California, San Francisco | 2017-05-15 |
| A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu) (NCT02727699) | Actinogen Medical | 2017-03-23 |
| Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA) (NCT03246269) | Andreas Monsch | 2016-12-01 |
| Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks (NCT03153371) | University of California, Los Angeles | 2016-04-04 |
| Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease (NCT02322021) | Eisai Inc. | 2014-11-26 |
| Home Evaluation of Exit Barriers in Wandering (NCT00997425) | US Department of Veterans Affairs | 2009-10-01 |
| Memantine Versus Donepezil in Early Stages of Alzheimer's Disease (NCT00505167) | Hospital Miguel Servet | 2007-07-01 |
| Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease (NCT00154635) | National Taiwan University Hospital | 2005-09-01 |
| Project COPE:Managing Dementia at Home (NCT00259454) | Thomas Jefferson University | 2005-06-01 |
| Pain Perception in Alzheimer's Disease (NCT00192816) | Rambam Health Care Campus | 2005-06-01 |
| TRx0014 in Patients With Mild or Moderate Alzheimer's Disease (NCT00515333) | TauRx Therapeutics Ltd | 2004-08-01 |
| A Comparison of Two Standard Therapies in the Management of Dementia With Agitation (NCT00208819) | Emory University | 2003-09-01 |
| Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type (NCT01438060) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2000-08-01 |